Term
|
Definition
Muscarinic agonist over nicotinic agonist
stimulates GI motility
contracts bladder |
|
|
Term
|
Definition
muscarinic agonist
induces vomiting
treates glaucoma
contracts ciliary muscle contraction |
|
|
Term
|
Definition
Muscarinic antagonist, alkaloid
preanesthetic, decreases respiratory secretion
treats vagal hyperactivity, decreases gastric motility, causes hypohidrosis, decreases lacrimation, xerostomia (dry mouth), myadrysis, urinary retention |
|
|
Term
|
Definition
| M1 antagonist, treats ulcers |
|
|
Term
|
Definition
| cholinergic agonistcauses vasodilation, treats ergot poisoning |
|
|
Term
|
Definition
| cholinergic agonist, treat colic and impaction |
|
|
Term
|
Definition
|
|
Term
|
Definition
muscarinic agonist
decrease heart rate and blood pressure
may cause dyspnea-bronchoconstriction |
|
|
Term
|
Definition
Reversible, cholinesterase inhibitor
causes miosis and decreases intraocular pressure, treats non-obstructive atony |
|
|
Term
|
Definition
| Reversible, cholinesterase inhibitor |
|
|
Term
|
Definition
| Reversible, cholinesterase inhibitor |
|
|
Term
|
Definition
| irreversible cholinesterase inhibitor |
|
|
Term
|
Definition
| reactivates cholinesterase |
|
|
Term
| DFP-diisopropyl phosphofluridate |
|
Definition
|
|
Term
| tetraethyl-phosphate (TEPP) |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| muscarinic antagonist, alkaloid |
|
|
Term
|
Definition
| muscarinic antagonist, alkaloid |
|
|
Term
|
Definition
| muscarinic antagonist, used s a preanesthetic, does not cause tachycardia, reduces gastric and respiratory secretions, lasts longer than atropine |
|
|
Term
|
Definition
| similar to atropine, shorter duration, fewer GI, CV side effects |
|
|
Term
|
Definition
D1 adrenergic receptor, improves tissue perfusion
partial agonist/antagonist
catecholamine |
|
|
Term
|
Definition
| B1 adrenergic agonist, dilates peripheral blood vessels, improves cardiac contractility, catecholamine |
|
|
Term
|
Definition
| D1, D2 agonist, improves renal bloodflow, increase cardiac contractility, catecholamine |
|
|
Term
|
Definition
| adrenergic agonist, CNS stimulant, respiratory stimulant, reverse barbituate, noncatecholamine |
|
|
Term
|
Definition
| non-cholaminergic agent, adrenergic agonist, nasal spray, decrease bleeding from surgical procedures |
|
|
Term
|
Definition
| non catecholamine, adrenergic agonist, causes weight reduction, treats urinary incontinence in dogs, |
|
|
Term
|
Definition
| non catecholamine, alpha and beta adrenergic agonist, |
|
|
Term
|
Definition
| B2 agonist, used to treat COPD |
|
|
Term
|
Definition
|
|
Term
|
Definition
| synthetic adrenergic antagonist, treats visceral ischemia due to circulatory shock |
|
|
Term
|
Definition
| synthetic adrenergic antagonist, treats visceral ischemia due to circulatory shock |
|
|
Term
|
Definition
| alpha 1 adrenergic antagonist |
|
|
Term
|
Definition
| alpha 2 adrenergic antagonist, reverse anesthesia in large wild animals |
|
|
Term
|
Definition
| beta adrenergic antagonist, treats atrial fibrillation or flutter |
|
|
Term
|
Definition
| beta adrenergic antagonist, treats atrial fibrillation or flutter |
|
|
Term
|
Definition
| beta adrenergic antagonist, treats atrial fibrillation or flutter |
|
|
Term
|
Definition
| prevent NE release, treats hypertension |
|
|
Term
|
Definition
|
|
Term
| Alpha methyl paratyrosine |
|
Definition
| blocks tyrosine hydroxylase, inhibits NE synthesis |
|
|
Term
|
Definition
| used for parkinson's, improve mood, mental health, increase catecholamine and serotonin in the brain |
|
|
Term
| Salicylate or carboxylic acid |
|
Definition
| NSAIDs, suppresses inflammation, prevent making arachidonic acid |
|
|
Term
|
Definition
| NSAIDs suppresses inflammation, prevent making arachidonic acid |
|
|
Term
|
Definition
| NSAIDs, suppresses inflammation, prevent making arachidonic acid |
|
|
Term
|
Definition
| NSAIDs, suppresses inflammation, prevent making arachidonic acid |
|
|
Term
|
Definition
| NSAIDs, suppresses inflammation, prevent making arachidonic acid may cause chronic renal failure, inhibits COX1 and 2, |
|
|
Term
|
Definition
| NSAIDs, suppresses inflammation, prevent making arachidonic acid |
|
|
Term
|
Definition
| NSAID, inhibits COX, stabilizes lysosomes, inhibits formation of kinins, antithrombotics, |
|
|
Term
|
Definition
| NSAID, small therapeutic index, treats arthritis, spondylitis, and laminitis |
|
|
Term
| Flunixin Meglumine (banamine) |
|
Definition
| NSAID, nicotinic acid derivative, analgesic, treats visceral pain, acute cow mastitis |
|
|
Term
|
Definition
| NSAID, treats soft tissue infflamation, large margin of safety |
|
|
Term
|
Definition
| NSAID, targets COX-2 only so limited gastric injury, postoperative analgesic, good for osteoarthritis, can affect cartilage formation |
|
|
Term
|
Definition
| NSAID, reversibly binds COX, causes gastric lesions |
|
|
Term
|
Definition
| NSAID, slow onset of action, treats laminitis |
|
|
Term
|
Definition
| NSAID, inhibits COX, LO and bradykinin |
|
|
Term
|
Definition
| NSAID, osteoarthritis in dogs, |
|
|
Term
|
Definition
| NSAID, treats osteoarthritis |
|
|
Term
| polysulfated glycoaminoglycan |
|
Definition
| chondroprotetctive, proteolytic enzymes are inhibited, lysosomes are stabilized |
|
|
Term
|
Definition
| dual pathway NSAID, blocks COX and lipoxygenase, decreases gastric irritation and ulceration, metabolized to its active form tepoxalin pyrazole acid, treats osteoarthritis |
|
|
Term
|
Definition
| NSAID, specific COX2 inhibitor |
|
|
Term
|
Definition
| lubricant in synovial fluid, inhibits phagocytosis and lymphocyte migration |
|
|
Term
| dimethyl sulfoxide (DMSO) |
|
Definition
| scavenges free radicals, useful for CNS inflammation, inhibits platelet aggregation, treats acute swelling, acute ofr chronic otitis, skin wounds, acral lick dermatitis |
|
|
Term
|
Definition
| steroidal anti-inflammatory, found in creams and ointments |
|
|
Term
|
Definition
| steroidal anti-inflammatory, converts to cortisol by the liver |
|
|
Term
|
Definition
| steroidal anti-inflammatory, converted by the liver into prednisolone, little to no mineralcorticoid effect |
|
|
Term
|
Definition
| steroidal anti-inflammatory, used if liver is non-functional, little to no mineralcorticoid effect |
|
|
Term
|
Definition
| steroidal anti-inflammatory, little to no mineralcorticoid effect |
|
|
Term
| isoflupredone or 9-flouroprednisolone |
|
Definition
| high power steroidal anti-inflammatory, used in large animals |
|
|
Term
|
Definition
| intermediate power steroidal anti-inflammatory,not ideal for alternate day therapy |
|
|
Term
|
Definition
| long acting steroidal anti-inflammatory, no mineralcorticoid effect, used more commonly in large animals due to cost and availability issues |
|
|
Term
|
Definition
| long acting steroidal anti-inflammatory, no mineralcorticoid effect, used more commonly in large animals due to |
|
|
Term
|
Definition
| long acting steroidal anti-inflammatory, no mineralcorticoid effect, used more commonly in large animals due to |
|
|
Term
|
Definition
|
|
